📢 Exciting announcement!
Resistomap has successfully raised €2M in a seed funding round led by impact investors Ananda Impact Venture, joined by co-investor Gaingels, with support from Business Finland's R&D grant!
Huge thank you for believing in our vision, and joining us to create a future where AMR is effectively monitored, understood, and managed, and where medical treatment remains able to save lives!
This funding comes at just the right time as focus intensifies on global biosecurity measures and initiatives like Wastewater-Based Epidemiology. We can now move forward with full speed to expand our monitoring services into a biosecurity intelligence platform designed to address environmental antimicrobial resistance (AMR).
AMR's severe impact on global health and substantial economic challenges underscore the urgency of addressing this issue, and our commitment is to enable proactive infection prevention. Our platform will feature the integration of early-warning systems, in-depth genetic results, advanced prediction models on the spread of AMR and personalised recommendations for reducing its dissemination.
Utilising our database which already contains a comprehensive analysis of over 10,000 environmental samples across 45 countries worldwide, we will work with stakeholders and experts to adapt to the needs of a broad range of users. Starting with wastewater treatment plants (WWTPs), and expanding into agri- and aquaculture industries, hospitals, long-term care facilities, pharmaceutical companies, food safety agencies, as well as public health authorities.
Follow us on our social media pages for further updates and developments!
💡 Follow us on our social media pages (@Resistomap) for further updates and developments
🌐 To get in touch with us, please head over to the contact section at (www.Resistomap.com/contact)
🌐 To find out more about Ananda Impact Ventures, please visit: (www.ananda.vc)